Form 4 Filing for Jon Faiz Kayyem
2026-09-23SEC Filing 4 (0001366268-26-000011)
On September 23, 2026, Jon Faiz Kayyem, a director at Inhibrx Biosciences, Inc. (INBX), acquired 5,000 shares of common stock through a trust. The transaction, coded as
On September 23, 2026, Jon Faiz Kayyem, a director at Inhibrx Biosciences, Inc. (INBX), acquired 5,000 shares of common stock through a trust. The transaction, coded as